Study of Autophagy and the Effects of GALIG Gene Products in HIV-1 Infected Patients Who Are Under Antiretroviral Therapy Since Primary-infection, Chronic Phase, or Never Treated.

Abroad (travel likely)Recruiting

Conditions

Autophagy · Galectins · HIV Infections · Highly Active Antiretroviral Therapy

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

CHU Orleans, Orléans, France
Contact: Study coordinator (Laurent HOCQUELOUX, Dr) · laurent.hocquelous@chr-orleans.fr
Contact: Principal Investigator (Laurent HOCQUELOUX, Dr)

Study leads

Laurent HOCQUELOUX, Dr
Principal Investigator
CHR d'orléans

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Effects of Miricell Supplementation on Biomarkers of Healthy Aging and Autophagy

Autophagy · Healthy Aging

Abroad (travel likely)Recruiting

Canfield, United States

A Phase Ib/II Study Confirmed Inhibition of Autophagy Synergizes Anti-tumor Effect of High Dose CDK4/6i

Inhibition of Autophagy Synergizes Anti-tumor Effect

Abroad (travel likely)RecruitingPHASE1, PHASE2

Guangzhou, China